The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

New guidelines released Wednesday recommend U.S. adults start colon cancer screening earlier, at age 45 instead of 50. The American Cancer Society's advice puts it out of sync with guidelines from an ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

Colon cancer remains a significant health concern, particularly within the Black community, where the disease disproportionately affects individuals. A recent study led by researcher Adjoa ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...

The Food and Drug Administration (FDA) has approved a new blood test to detect colon cancer. The blood test, manufactured by Guardant Health’s Shield, does not replace colonoscopies. Colorectal cancer ...

Starting next month, Ontarians who are 45 years old will be eligible for colorectal cancer screening. Some patients and ...